3rd Mar 2014 16:25
LONDON (Alliance News) - Dechra Pharmaceuticals PLC Monday said Chief Executive Ian Page and company secretary Zoe Goulding exercised options, and sold shares pursuant to the Dechra Pharmaceuticals Long Term Incentive Plan Friday.
Details are as follows.
Name | Capacity | Options Exercised | Shares Sold | Sale Price per share
| Total beneficial shareholding following this announcement | Percentage of issued share capital |
Ian Page | Director | 78,656 | 37,080 | £6.9129 | 906,643 | 1.035 |
Zoe Goulding | PDMR | 8,989 | 4,238 | £6.9129 | 11,933 | 0.014 |
Shares in the phama company were down 2.6% at 683.50 pence Monday.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
DPH.L